作者投稿
专家审稿
编辑办公
邮件订阅
RSS
Brief Review of the 3T's Roadmap of Translational Medicine for Parenteral and Enteral Nutrition in China
-
摘要: 截至2020年，中国肠外肠内营养学已经历从实验室研究到临床应用(Translation 1, T1)、大样本临床有效性研究(Translation 2, T2)，分步进入测算医疗质量及成本-效果(Translation 3, T3)的发展时期。中华医学会肠外肠内营养学分会营养风险-不足-支持-结局-成本效果比多中心分享数据库协作组借鉴国际转化医学3T路线图，在中国开拓了肠外肠内营养学领域的T3阶段转化研究，包括卫生经济学研究。目前，中国肠外肠内营养学领域需开展“合理应用，患者受益”有关的临床研究，如营养风险筛查及营养不良诊断的临床有效性研究，以及营养用药有关的卫生经济学研究。Abstract: Till 2020, parenteral and enteral nutrition in China has moved from Translation 1 (T1), and then Translation 2 (T2), to Translation 3 (T3) now. The T3 transfer requires the evaluation of medical services' quality and cost-effectiveness research. After learning from international published articles, the multicenter cooperative database group of Chinese Society for Parenteral and Enteral Nutrition (CSPEN) on Nutritional risk, Undernutrition, Support, Outcome, and Cost-effectiveness ratio (NUSOC) (abbreviated to CSPEN-NUSOC Cooperative Group) has made efforts to promote health economics research in the field of parenteral and enteral nutrition in China. This paper reviewed the translational medical research of parenteral and enteral nutrition in China. At present, clinical studies toward the goal of "reasonable use to benefit patients"should be conducted in parenteral and enteral nutrition field in China, such as clinical effectiveness study of nutritional risk screening 2002 and Global Leadership Initiative on Malnutrition criteria, or health economics study on nutritional drug.利益冲突：无蒋朱明、 李卓为本文共同第一作者
-
[1] Choi DW. Bench to bedside: the glutamate connection[J]. Science, 1992, 258:241-243. doi: 10.1126/science.1357748 [2] Mulshine JL, Jett M, Cuttitta F, et al. Scientific basis for cancer prevention intermediate cancer markers[J]. Cancer, 1993, 72: 978-983. doi: 10.1002/1097-0142(19930801)72:3+<978::AID-CNCR2820721305>3.0.CO;2-T [3] Geraghty J. Adenomatous polyposis coli and translational medicine[J]. Lancet, 1996, 348: 422. http://www.sciencedirect.com/science/article/pii/S0140673605645357 [4] Zerhouni E. The NIH Roadmap[J]. Science, 2003, 302: 63-72. doi: 10.1126/science.1091867 [5] Dougherty D, Conway PH. The "3T's" road map to transform US health care: the "how" of high-quality care[J]. JAMA, 2008, 299: 2319-2321. doi: 10.1001/jama.299.19.2319 [6] 蒋朱明, 曾宪九, 朱预, 等.静脉高营养[M]//中国医学科学院首都医院.水与电解质平衡.北京: 人民卫生出版社, 1974: 477-489. [7] 蒋朱明, 朱预, 张思源.静脉营养治疗外科危重病人[C].中华医学会.第九届全国外科学术会议论文摘要, 1978: 273. [8] 蒋朱明, 朱预, 张思源, 等.静脉营养与要素饮食用于肠瘘[J].中华外科杂志, 1979, 17: 40-43. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhwk197901111 [9] 吴肇汉, 吴肇光.外科重危病人应用静脉营养疗法的一些体会[J].上海医学, 1979, 2: 19-23. http://www.cnki.com.cn/Article/CJFDTotal-SHYX197901009.htm [10] 邹忠寿, 黎介寿, 顾寿年.静脉高价营养疗法在儿外科的应用[J].江苏医药, 1979:5-7. http://www.cnki.com.cn/Article/CJFDTotal-YIYA197905003.htm [11] 蒋耀光, 周月庆.要素饮食在外科临床的应用[J].人民军医, 1979, 30: 78-81. http://epub.cnki.net/grid2008/docdown/docdownload.aspx?filename=RMJZ197905038&dbcode=CJFD&year=1979&dflag=pdfdown [12] 雷政宏, 安娜, 郑渝英, 等.烧伤病人静脉高价营养护理[J].第三军医大学学报, 1979, 1: 120-123. http://www.cnki.com.cn/Article/CJFDTotal-DSDX197904024.htm [13] Braga M, Gianotti L. Preoperative immunonutrition: cost-benefit analysis[J]. JPEN J Parenter Enteral Nutr, 2005, 29: S57-S61. http://europepmc.org/abstract/MED/15709546 [14] Jiang ZM, Chen W, Zhan WH, et al. Parenteral and enteral nutrition application in west, middle and east China: a multicenter investigation for 15098 patients in 13 metropolitans using nutritional risk screening 2002 tool[J]. Clin Nutr Suppl, 2007, 2:133-134. [15] 工信部.中国区块链技术和应用发展白皮书[R]. 2016: 23. [16] Liang XK, Jiang ZM, Nolan MT, et al. Comparative survey on nutritional risk and nutritional support between Beijing and Baltimore teaching hospitals[J]. Nutrition, 2008, 24: 969-976. doi: 10.1016/j.nut.2008.05.001 [17] Liang XK, Jiang ZM, Nolan MT, et al. Nutritional risk, malnutrition (undernutrition), overweight, obesity and nutrition support among hospitalized patients in Beijing teaching hospitals[J]. Asia Pac J Clin Nutr, 2009, 18: 54-62. http://europepmc.org/abstract/MED/19329396 [18] 蒋朱明, 于康, 朱赛楠, 等.我国东, 中, 西部中小医院住院患者营养不良(不足), 营养风险, 超重和肥胖发生率及营养支持应用状况调查(中期小结)[J].中国临床营养杂志, 2008, 16: 338-340. http://www.cnki.com.cn/Article/CJFDTotal-ZGLZ200806006.htm [19] 蒋朱明, 陈伟, 朱赛楠, 等.我国东、中、西部大城市三甲医院营养不良(不足)、营养风险发生率及营养支持应用状况调查[J].中国临床营养杂志, 2008, 16: 335-337. http://www.cnki.com.cn/article/cjfdtotal-zglz200806005.htm [20] Jie B, Jiang ZM, Nolan MT, et al. Impact of nutritional support on clinical outcome in patients at nutritional risk: a multicenter, prospective cohort study in Baltimore and Beijing teaching hospitals[J]. Nutrition, 2010, 26: 1088-1093. doi: 10.1016/j.nut.2009.08.027 [21] Jie B, Jiang ZM, Nolan MT, et al. Impact of preoperative nutritional support on clinical outcome in abdominal surgical patients at nutritional risk[J]. Nutrition, 2012, 28: 1022-1027. doi: 10.1016/j.nut.2012.01.017 [22] 王艳, 蒋朱明, 王杨, 等.营养支持对有营养风险胃肠病患者临床结局的影响以及成本-效果比初步探讨: 275例前瞻性队列研究[J].中华临床营养杂志, 2013, 21: 333-338. http://d.wanfangdata.com.cn/Periodical/zglcyyzz201306002 [23] Zhang H, Wang Y, Jiang ZM, et al. Impact of nutrition support on clinical outcome and cost-effectiveness analysis in patients at nutritional risk: A prospective cohort study with propensity score matching[J]. Nutrition, 2017, 37: 53-59. doi: 10.1016/j.nut.2016.12.004 [24] Kondrup J, Rasmussen HH, Hamberg O, et al. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials[J]. Clin Nutr, 2003, 22: 321-336. doi: 10.1016/S0261-5614(02)00214-5 [25] Kondrup J, Allison SP, Elia M, et al. ESPEN guidelines for nutrition screening 2002[J]. Clin Nutr, 2003, 22: 415-421. doi: 10.1016/S0261-5614(03)00098-0 [26] 刘国恩, 胡善联, 吴久鸿.中国药物经济学评价指南[J].中国药物经济学, 2011, 3: 6-48. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgywjjx201005001 [27] 揭彬, 蒋朱明.肠外或肠内营养支持对有营养风险患者临床结局的影响[J].中华临床营养杂志, 2009, 17: 127-128. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zglcyyzz200902020 -
下载:
点击查看大图
图(1)
计量
- 文章访问数: 382
- HTML全文浏览量: 103
- PDF下载量: 46
- 被引次数: 0
